ABCA3 |
ATP Binding Cassette Subfamily A Member 3 |
ABC |
ATP-binding cassette |
ALL |
Acute lymphoblastic leukemia |
AML |
Acute myeloid leukemia |
ADCC |
antibody-dependent cell-mediated cytotoxicity |
ADME |
absorption, distribution, metabolism and elimination |
ALIX |
apoptosis linked gene 2 |
BCL9 |
B-cell lymphoma 9 |
BIM |
B-cell lymphoma-2 [BCL-2]–interacting mediator of cell death |
BM |
bone marrow |
BMME |
bone marrow microenvironment |
BMSCs |
bone marrow stromal cells |
Btz |
bortezomib |
CAECs |
cancer-associated endothelial cells |
CAFs |
cancer-associated fibroblasts |
CAV1 |
Caveolin 1 |
CFU |
colony forming unit |
CLL |
Chronic lymphocytic leukemia |
CML |
Chronic myeloid leukemia |
CNS |
central nervous system |
CSC |
cancer stem cells |
DLBCL |
diffuse large B-cell lymphoma |
DR |
drug resistance |
ECM |
extracellular matrix |
EMT |
epithelium-mesenchyme transition |
ESCRT |
endosomal sorting complexes required for transport |
EVs |
extracellular vesicles |
FDCs |
Follicular dendritic cells |
GR |
glucocorticoid receptor |
GTPases |
guanosine triphosphase |
HCC |
hepatocellular carcinoma |
HDAC6 |
histone deacetylase 6 |
HL |
Hodgkin’s lymphoma |
hnRNPA2B1 |
Heterogeneous Nuclear Ribonucleoproteins A2/B1 |
HSCs |
hematopoietic stem cells |
HUVECs |
human vascular endothelial cells |
ICAM-1 |
intercellular adhesion molecule-1 |
IL |
interleukin |
ILV |
intraluminal vesicles |
IM |
imatinib |
IVs |
intracellular vesicles |
LAM |
lymphoma-associated macrophages |
lncRNAs |
long non-coding RNAs |
LSCs |
leukemic stem cells |
MAPK |
MAP kinases |
MDR |
multiple-DR |
MGUS |
Monoclonal Gammopathy of Indeterminate Significance |
miRNA |
micro-RNA |
MM |
Multiple myeloma |
MMP |
matrix metalloproteinase |
MSC |
mesenchymal stem/stromal cells |
mTOR |
mechanistic target of rapamycin |
mRNA |
messenger RNA |
MSCs |
mesenchymal stem cells |
MVBs |
multivesicular bodies |
NF-kB |
nuclear factor kappa-light-chain-enhancer of activated B cells |
NHL |
non-Hodgkin’s lymphoma |
NK |
natural killer |
OPG |
degrading osteoprotegerin |
OXPHOS |
oxidative phosphorylation |
PARP |
ADP-ribose polymerase |
PCs |
plasmacells |
P-gp |
p-glycoprotein |
Ph |
Philadelphia chromosome |
PI |
proteasome inhibitor |
PI3K |
PhosphatidylInositol 3-Kinase |
PKM2 |
Pyruvate Kinase M2 |
PTEN |
Phosphatase and tensin homolog |
RS |
Reed Sternberg cell |
SF |
soluble factors |
SPHK2 |
Sphingosine-1-phosphate, sphingosine kinase 2 |
SMART-exos |
Synthetic Multivalent Antibodies ReTargeted Exosomes |
SNARE |
the soluble N-ethylmaleimide-sensitive factor attachment protein receptor |
TAFs |
Tumor-associated fibroblasts |
TAMs |
tumor-associated macrophages |
TASCs |
Tumor-associated stromal cells |
TGFβ1 |
Transforming growth factor beta 1 |
Th |
helper T cells |
TFH |
follicular helper T cells |
TKIs |
tyrosine kinase inhibitors |
TME |
Tumor microenvironment |
Treg |
regulatory T cells |
VEGF |
Vascular-Endothelial Growth Factor |
VCAM-1 |
vascular cell adhesion molecule-1 |
VTA1 |
vesicle trafficking |